fashion -WSS

fashion

author：hotspot 2025-09-05 09:20:20 - browse：333

Sammy Kimball for STAT

Who’s watching the drug price watchmen? Are RSV vaccines too expensive? And is it finally time for Novavax to shine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Bob Herman joins us to explain his year-long investigation into some brazen conflicts of interest in the world of prescription drug pricing. Then, STAT’s Helen Branswell calls in to walk us through a news-packed week for vaccines, including weighty decisions for Covid-19 and RSV.

For more on what we cover, here’s the story on conflicts of interest; here’s the latest on RSV vaccines; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Psychedelics group wrestles with new pharma identity
Next article： The EU Joint Clinical Assessment needs to live up to its promise

entertainment

WSS

CEOs share strategies for surviving biotech slump

Novo acquires Inversago for up to $1 billion

White House drug shortages task force keeps mum with Congress

Hospital price transparency does save money, advocate argues

Novo acquires Inversago for up to $1 billion

Pharmacists can make shortage drugs, but at what cost?

hotspot

fashion

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Impact of Dobbs ruling felt at reproductive medicine meeting

Cancer drug shortages should be causing more outrage

TB outbreak tied to bone grafts underscores testing shortcomings

Trump demands the U.S. pay no more for drugs than other countries … again

FDA gives detailed accounting of AI

Duchenne breakthrough therapy leaves behind pioneering families

Lawmakers consider Medicare pay reforms for doctors

Wildfire smoke exposes gaps in outdoor worker protections

Large hospital system sues Multiplan for low

hotspot

CEOs share strategies for surviving biotech slump

Genentech weighs delaying cancer therapy after drug pricing law

STAT Summit: Biotech founders on deal

NIH confirmation hearing shows politicization of research

First Opinion Podcast: Long Covid needs a new approach

CDC overhauls leadership of center that led response to Covid

leisure time

knowledge

entertainment

focus